On this page
What each program costs in New Jersey
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the New Jersey State Health Benefits Program (SHBP) cover GLP-1s for weight loss?
New Jersey's State Health Benefits Program covers Wegovy, Saxenda and Zepbound for weight loss in 2026, at a $45 copay for a 30-day retail supply or $135 for a 90-day mail-order supply.
Does New Jersey Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
New Jersey Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.
Weight loss
Not covered, January 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
10,214 prescriptions
Ozempic and Mounjaro, 2025
102,689 prescriptions
Neighbours covering weight loss
0 of 3
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. KFF counts coverage under fee-for-service; if your New Jersey Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
What may have changed since January
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether New Jersey Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does New Jersey Medicaid pay for?
165,515 GLP-1 prescriptions in 2025, 18th of the 50 states and DC, with $148.5 million reimbursed before rebates. Counting the share other payers covered, $151.3 million.
Prescriptions, 2025
165,515
18th of 51
Medicaid paid
$148.5M
18th of 51, before rebates
Per prescription
$897
$1,051 nationally
Weight-loss brands
6.2%
21st highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. New Jersey is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 6.2% of New Jersey Medicaid's GLP-1 prescriptions in 2025 (10,214). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was New Jersey Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 64,809 | 39% | $63.5 million | $979 |
| Mounjaro | 37,880 | 23% | $39.9 million | $1,054 |
| Liraglutide (generic) | 30,995 | 19% | $13.5 million | $434 |
| Trulicity | 12,746 | 7.7% | $12.1 million | $947 |
| Zepboundapproved for weight management | 6,385 | 3.9% | $6.8 million | $1,071 |
| Bydureon | 6,107 | 3.7% | $5.0 million | $812 |
| Wegovyapproved for weight management | 3,829 | 2.3% | $5.1 million | $1,325 |
| Rybelsus | 2,764 | 1.7% | $2.7 million | $979 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in New Jersey?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 8 in New Jersey. The register does not say which, if any, supplies a program on this page.
- Denver Solutions, LLC, dba Leiters Health, Buena. Registered since Jul 1, 2022; not yet inspected by FDA.
- Empower Clinic Services New Jersey, East Windsor. Registered since Jun 10, 2024; not yet inspected by FDA.
- Hyalo Technologies Limited Liability Company, Somerset. Registered since May 1, 2025; not yet inspected by FDA.
- Imprimis NJOF, LLC, Ledgewood. Registered since Nov 12, 2016; last FDA inspection Aug 18, 2026.
- Molecular PharmaGroup, New Providence. Registered since May 8, 2018; last FDA inspection Nov 13, 2026.
- Quva Pharma, Inc., Bloomsbury. Registered since Sep 15, 2017; last FDA inspection Nov 13, 2026.
- Sankav Pharmaceuticals, LLC, Hackettstown. Registered since Mar 21, 2025; not yet inspected by FDA.
- Stokes Healthcare Inc., dba Epicur Pharma, Mt. Laurel. Registered since Jan 30, 2018; last FDA inspection May 23, 2025.
On Medicare in New Jersey?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
New Jersey and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
None of the 3 states next to New Jersey covers GLP-1s for weight loss through Medicaid. None has a lower cash floor than New Jersey's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| New Jersey | Not covered | 19 | $39/mo |
| Delaware | Documents conflict | 19 | $39/moWellmedr |
| New York | Not covered | 19 | $39/moWellmedr |
| Pennsylvania | Not covered | 19 | $39/moWellmedr |






















